| Primary cilia sensitize endothelial cells to BMP and prevent excessive vascular regression AC Vion, S Alt, A Klaus-Bergmann, A Szymborska, T Zheng, T Perovic, ... Journal of Cell Biology 217 (5), 1651-1665, 2018 | 97 | 2018 |
| Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion–positive supratentorial ependymomas T Zheng, DR Ghasemi, K Okonechnikov, A Korshunov, M Sill, KK Maass, ... Cancer discovery 11 (9), 2230-2247, 2021 | 56 | 2021 |
| ZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors R Kupp, L Ruff, S Terranova, E Nathan, S Ballereau, R Stark, ... Cancer discovery 11 (9), 2216-2229, 2021 | 53 | 2021 |
| Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors P Sievers, SC Henneken, C Blume, M Sill, D Schrimpf, D Stichel, ... Acta neuropathologica 142 (5), 827-839, 2021 | 49 | 2021 |
| Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas. Cancer Discov. 2021 doi: 10.1158/2159-8290 T Zheng, DR Ghasemi, K Okonechnikov, A Korshunov, M Sill, KK Maass, ... CD-20-0963.[Abstract][CrossRef][Google Scholar], 0 | 11 | |
| ZFTA-translocations constitute ependymoma chromatin remodeling and transcription factors. Cancer Discov R Kupp, L Ruff, S Terranova, E Nathan, S Ballereau, R Stark, ... | 5 | 2021 |
| EPEN-03. Zfta/c11orf95 fusions drive supratentorial ependymoma via shared oncogenic mechanisms T Zheng, DR Ghasemi, K Okonechnikov, A Korshunov, KK Maaß, M Sill, ... Neuro-oncology 23 (Supplement_1), i13-i14, 2021 | 1 | 2021 |
| METB-03. SOLID PEDIATRIC TUMORS IN MICE REVEAL MODEL-SPECIFIC GLOBAL DNA METHYLATION AND CNV PROFILES CORRESPONDING TO HUMAN COUNTERPARTS M Schoof, T Zheng, M Sill, R Imle, N Hofmann, K Ernst, D Vonficht, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| HGG-14. COMPARING THE RADIOSENSITIZATION POTENTIAL OF VARIOUS COMPOUND CLASSES IN PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMA A Cais, S Lipiec, KCH Chan, N Hofmann, C Gade, L von Soosten, R Imle, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma Development A Kardian, H Sun, S Ippagunta, N Laboe, HC Chen, E Emanus, ... bioRxiv, 2024.08. 12.607603, 2024 | | 2024 |
| MODL-07. DNA methylation-based biobank of murine models for pediatric tumors T Zheng, M Sill, R Imle, R Shiraishi, W Wang, A Morcavallo, L Chesler, ... Neuro-Oncology 24 (Suppl 1), i169, 2022 | | 2022 |
| OS06. 4A Identification of T cell receptors targeting ZFTA-RELA fusion-positive ependymoma N Kehl, M Friedrich, M Kilian, T Zheng, K Pajtler, L Bunse, M Platten Neuro-oncology 23 (Suppl 2), ii9, 2021 | | 2021 |
| C11orf95 genomic rearrangements dictate oncogenic dependence in supratentorial brain tumors. D Kawauchi, T Zheng, DR Ghasemi, K Okonechnikov, SM Pfister, F Sahm, ... CANCER SCIENCE 112, 1000-1000, 2021 | | 2021 |
| EPEN-18. CROSS-SPECIES GENOMICS IDENTIFIES GLI2 AS AN ONCOGENE OF C11ORF95 FUSION-POSITIVE SUPRATENTORIAL EPENDYMOMA E Kagan, D Brat, A Shilatifard, A Piunti, O Becher Neuro-oncology, 2020 | | 2020 |
| Abstract B71: Molecular heterogeneity and novel oncogenic fusions in RELA- and YAP1-negative supratentorial ependymoma DR Ghasemi, K Okonechnikov, A Korshunov, M Sill, T Zheng, ... Cancer Research 80 (14_Supplement), B71-B71, 2020 | | 2020 |
| Molecular heterogeneity and novel oncogenic fusions in RELA-and YAP1-negative supratentorial ependymoma DR Ghasemi, K Okonechnikov, A Korshunov, M Sill, T Zheng, ... CANCER RESEARCH 80 (14), 115-116, 2020 | | 2020 |
